Target intelligence / Profile preview

Prostasin (PRSS8)

Target
PRSS8
Molecular classification
Enzyme, Serine protease, Membrane-anchored protease, Trypsin family
01

Overview

Prostasin (PRSS8) is a membrane-bound serine protease of the trypsin family, highly expressed in epithelial tissues such as the prostate, lung, and skin[5][6]. Its principal roles include promoting terminal differentiation in epithelia and regulating epithelial sodium channel (ENaC) activity, essential for sodium and water homeostasis. Prostasin achieves its functions both through its enzymatic activity and via non-catalytic mechanisms, as demonstrated by mouse models where enzymatic inactivation does not abrogate key biological functions[4]. Disease associations primarily relate to barrier dysfunction, dehydration, and conditions involving abnormal sodium transport. Experimental and pharmacological efforts to target prostasin focus on protease inhibition, which may impact epithelial integrity and fluid balance.

Other names
Channel-activating protease 1 (CAP1)PRSS8Prostasin
02

Mechanism of action

Protease inhibitors can block the catalytic site of prostasin, typically by mimicking substrate and forming stable complexes. Regulation/inhibition of enzymatic activity impacts ENaC channel function, affecting salt and water absorption[4][5].

03

Biological functions

Epithelial barrier formationRegulation of epithelial sodium channel (ENaC) activityHomeostasis of epithelial tissueCell surface proteolytic cascade
04

Disease associations

Impaired epidermal barrier (e.g., dehydration, placental insufficiency)Potentially involved in hypertension and other diseases linked to sodium transportOther roles under investigation in cancer and inflammation
05

Safety considerations

Over-inhibition of prostasin can lead to impaired epithelial barrier function, dehydration, and increased susceptibility to damage or infectionLoss or mutation can result in fatal developmental disorders in model organisms
06

Interacting drugs

There are currently no widely approved drugs that directly target prostasin, but inhibitors of proteases, especially serine proteases, are under investigation.
07

Biomarkers

Expression of PRSS8 in epithelial tissues can serve as a biomarker for epithelial integrity and barrier function

Beyond the preview

Go deeper on Prostasin (PRSS8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prostasin (PRSS8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call